Morgan Stanley »

Gt Biopharma shares owned by Morgan Stanley

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $752 266 2.83
2024-03-31 $1.2k 266 4.43

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Gt Biopharma

DekaBank Deutsche Girozentrale
Geode Capital Management
Vanguard Group
Susquehanna International
Wells Fargo & Company
BlackRock
BlackRock
Tower Research Capital
Morgan Stanley
Bank of America Corporation
Advisor Group Holdings
Blue Bell Private Wealth Management
Bnp Paribas Arbitrage, Snc
Royal Bank of Canada
Jpmorgan Chase & Co

View all funds holding Gt Biopharma